Sale!

PIK3R5 Gene Ataxia-Oculomotor Apraxia Type 3 Genetic Test Cost

Name: PIK3R5 Gene Ataxia-Oculomotor Apraxia Type 3 Genetic Test Cost
SKU: TEST-1078
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PIK3R5 Gene Ataxia-Oculomotor Apraxia Type 3 Genetic Test is a specialized diagnostic tool designed to detect mutations in the PIK3R5 gene, which are associated with Ataxia-Oculomotor Apraxia Type 3 (AOA3). AOA3 is a rare genetic disorder characterized by a combination of ataxia (lack of muscle coordination) and oculomotor apraxia (difficulty in moving the eyes on command), among other symptoms. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, enabling targeted interventions and counseling for affected individuals and their families.

This test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable results. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of AOA3, paving the way for personalized treatment plans and better understanding of the condition’s progression and impact.

Description

PIK3R5 Gene Ataxia-oculomotor apraxia type 3 Genetic Test

Test Name: PIK3R5 Gene Ataxia-oculomotor apraxia type 3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PIK3R5 Gene Ataxia-oculomotor apraxia type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIK3R5 Gene Ataxia-oculomotor apraxia type 3

Test Details: The PIK3R5 gene is associated with Ataxia-oculomotor apraxia type 3 (AOA3), a rare neurodegenerative disorder characterized by progressive ataxia, oculomotor apraxia, peripheral neuropathy, and cerebellar atrophy. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the PIK3R5 gene. This test involves sequencing the DNA of an individual to detect any changes or variations in the gene sequence that may be associated with AOA3. Genetic testing can help diagnose AOA3 and provide information about the inheritance pattern of the condition. It can also help identify carriers of the gene mutation, which may be useful for family planning and genetic counseling. It is important to note that genetic testing is not always necessary or appropriate for everyone with symptoms of AOA3. A clinical evaluation by a healthcare provider is usually the first step in diagnosis and management of this condition.

Test Name	PIK3R5 Gene Ataxia-oculomotor apraxia type 3 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PIK3R5 Gene Ataxia-oculomotor apraxia type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PIK3R5 Gene Ataxia-oculomotor apraxia type 3
Test Details	The PIK3R5 gene is associated with Ataxia-oculomotor apraxia type 3 (AOA3), a rare neurodegenerative disorder characterized by progressive ataxia, oculomotor apraxia, peripheral neuropathy, and cerebellar atrophy. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the PIK3R5 gene. This test involves sequencing the DNA of an individual to detect any changes or variations in the gene sequence that may be associated with AOA3. Genetic testing can help diagnose AOA3 and provide information about the inheritance pattern of the condition. It can also help identify carriers of the gene mutation, which may be useful for family planning and genetic counseling. It is important to note that genetic testing is not always necessary or appropriate for everyone with symptoms of AOA3. A clinical evaluation by a healthcare provider is usually the first step in diagnosis and management of this condition.